Free Trial
OTCMKTS:GNGBY

Getinge 1/28/2025 Earnings Report

Getinge logo
$19.53 +0.01 (+0.05%)
As of 03:50 PM Eastern

Getinge EPS Results

Actual EPS
$0.49
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Getinge Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Getinge Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Getinge's next earnings date is estimated for Friday, July 18, 2025, based on past reporting schedules.

Conference Call Resources

Getinge Earnings Headlines

GNGBY Getinge AB (publ) - Seeking Alpha
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Getinge Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Getinge? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Getinge and other key companies, straight to your email.

About Getinge

Getinge (OTCMKTS:GNGBY) (OTCMKTS:GNGBY) is a global medical technology company headquartered in Gothenburg, Sweden, offering equipment and systems that support healthcare and life sciences. Founded in 1904 in the small town of Getinge, the company has grown from its early roots as a pump manufacturer to a diversified provider of acute care, infection control and life science solutions. Getinge’s product range spans ventilators, anesthesia machines and heart–lung bypass systems for critical care, as well as surgical tables, lights and support systems for the operating room.

In its Infection Control division, Getinge supplies sterilization equipment, washer-disinfectors and endoscope reprocessing systems designed to reduce risk of healthcare-associated infections. The company complements its capital equipment with a full portfolio of single-use consumables and service contracts, ensuring ongoing performance, training and technical support for hospital clients. Its Life Science segment addresses biopharmaceutical and laboratory markets by delivering isolators, bio-reactors and containment solutions that help researchers and manufacturers maintain sterile environments.

Operating in more than 40 countries, Getinge serves a broad geographic footprint that includes Europe, North America, Latin America, Asia Pacific and emerging markets. The company maintains manufacturing facilities in Europe and Asia, together with a global sales and service network that provides installation, maintenance and training. This geographic diversity enables Getinge to address regional regulatory requirements and adapt its offerings to local healthcare needs and infrastructure.

Getinge’s leadership team is headed by President and CEO Mattias Perjos, who joined the company in April 2022 and brings extensive experience in medical technology and industrial operations. The board of directors is chaired by Carl Bennet, a longstanding investor in the company. Under this leadership, Getinge continues to pursue innovation in areas such as digital monitoring, data analytics and automation to enhance patient outcomes and operational efficiency for healthcare providers worldwide.

View Getinge Profile

More Earnings Resources from MarketBeat